Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 30, 2016
X-Chem, a privately held biotechnology company applying its DNA-Encoded X-Chem (DEX™) drug discovery platform to generate novel therapeutics, has announced that a licensing option with Janssen Biotech, Inc., one of the Janssen Pharmaceutical ...
read more
Tuesday, October 08, 2019
AGC Biologics announced the appointment of Jeffery D. Mowery as Site Head/General Manager of the Copenhagen, Denmark facility.
read more
Wednesday, February 10, 2021
Alphageneron has signed an Exclusive License Agreement with Multimmune for its clinical stage autologous NK cell therapy and companion diagnostic platform.
read more
Wednesday, January 17, 2018
Pharmaceutical Product Development and Quotient Sciences announced a new collaboration to accelerate pediatric drug development.
read more
Tuesday, December 08, 2020
SeaCube recently acquired 200 Carrier Pods monitored by Sensitech to help address the anticipated increase in demand for refrigerated storage capacity for COVID-19 vaccine distribution.
read more
Wednesday, April 18, 2012
BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and speak at several upcoming industry conferences in April, May, and June. BioClinica ...
read more
Veranova announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus.
read more
Friday, September 06, 2019
Eagle has announced the opening of its new headquarters in southwest Houston.
read more
Illumina and Pacific Biosciences of California have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018.
read more
Quotient Sciences announced the launch of Arcinova - a science-driven service brand for early development that will operate within Quotient Sciences.
read more
Specialist Biometrics CRO, Veramed, announced the appointment of Karen Curran as Chief Strategy Officer at Veramed. Karen joins during a period of substantial global growth for the company.
read more
Clinical Ink has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.
read more
Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment...
read more
Wednesday, September 14, 2022
WCG announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators. Launched in conjunction with the opening of Dr. Vince Clinical Research’s (DVCR) industry-leading, green-designed research ...
read more
Cambrex announced it is investing $3.6 million at its Karlskoga, Sweden facility to increase flexible drug substance manufacturing capacity.
read more